Nuance Biotech (Shanghai) Co. Ltd
was founded in 2014.
Leading China based biotech company focussed on commercial, regulatory and development stage assets.
Nuance is directed by a world class board of directors and managed by an experienced China based management team with a strong track record.
Backed a leading global tier 1 investor with more than USD 1 billion under management in China – Matrix Partners.
The company strategy and approach allows for a highly scalable commercial and drug development model i.e. ability to run multiple initiatives.
Through China's Specialty Pharmaceuticals Market !